Although malakoplakia has been reported in other immunocompromised states, including primary immunodeficiencies and transplant recipients, its occurrence in APDS has not been previously described, suggesting profound immune dysregulation possibly mediated by hyperactivation of the PI3K/AKT/mTOR pathway [7,4,11,12]. This evidence concerns the gene MTOR and malakoplakia.